SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-009269
Filing Date
2017-05-15
Accepted
2017-05-15 17:00:55
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20170331_10q.htm 10-Q 487391
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10342
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10760
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5033
  Complete submission text file 0001437749-17-009269.txt   2713990

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT wint-20170331.xml EX-101.INS 440426
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20170331.xsd EX-101.SCH 33891
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20170331_cal.xml EX-101.CAL 26569
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20170331_def.xml EX-101.DEF 236293
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20170331_lab.xml EX-101.LAB 213952
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20170331_pre.xml EX-101.PRE 248351
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26422 | Film No.: 17845427
SIC: 2836 Biological Products, (No Diagnostic Substances)